Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma
Authors:
- Uwe ReinholdURUwe Reinhold
- Christoph HartlCHChristoph Hartl
- Rudolf HeringRHRudolf Hering
- Andreas HoeftAHAndreas Hoeft
- Hans-Wilhelm KreyselHKHans-Wilhelm Kreysel
- 1 February 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9051) , 540-541
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaCancer, 1995
- Drug Points: Rhabdomyolysis after treatment with interferon alfaBMJ, 1994